Form D — Amphix Bio, Inc.
0002101704-25-000001 · filed 2025-12-19
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $12,500,000
- Total sold
- $10,300,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Amphix Bio, Inc.
- CIK
- 2101704
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 400 N. ABERDEEN ST.
CHICAGO, IL 60642 - Phone
- 720-840-7327
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Nicholas Sather · Executive OfficerChicago, IL Find on LinkedIn ↗
-
Samuel Stupp · Executive OfficerChicago, IL Find on LinkedIn ↗
-
Kok-Wai Wong · DirectorChicago, IL Find on LinkedIn ↗
-
John Potocsnak · DirectorChicago, IL Find on LinkedIn ↗
-
Stephen R Wilson · DirectorChicago, IL Find on LinkedIn ↗
View original on SEC EDGAR.